Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Natera 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Leonard Chapman
CEOStephen Leonard Chapman
Employees
6,140
Employees6,140
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
6,140
Employees6,140

NTRA Key Statistics

Market cap
27.78B
Market cap27.78B
Price-Earnings ratio
-127.62
Price-Earnings ratio-127.62
Dividend yield
Dividend yield
Average volume
1.46M
Average volume1.46M
High today
$207.78
High today$207.78
Low today
$194.29
Low today$194.29
Open price
$205.01
Open price$205.01
Volume
1.85M
Volume1.85M
52 Week high
$256.36
52 Week high$256.36
52 Week low
$131.81
52 Week low$131.81

Stock Snapshot

The current Natera(NTRA) stock price is $196.11, with a market capitalization of 27.78B. The stock trades at a price-to-earnings (P/E) ratio of -127.62.

On 2026-04-16, Natera(NTRA) stock traded between a low of $194.29 and a high of $207.78. Shares are currently priced at $196.11, which is +0.9% above the low and -5.6% below the high.

Natera(NTRA) shares are trading with a volume of 1.85M, against a daily average of 1.46M.

During the past year, Natera(NTRA) stock moved between $131.81 at its lowest and $256.36 at its peak.

During the past year, Natera(NTRA) stock moved between $131.81 at its lowest and $256.36 at its peak.

NTRA News

Simply Wall St 2d
Is It Time To Reassess Natera After Its Mixed Share Price Performance?

If you are wondering whether Natera's current share price reflects its true worth, this article walks through the key numbers that matter before you commit fres...

Is It Time To Reassess Natera After Its Mixed Share Price Performance?
Benzinga 2d
Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst

MRD refers to the small number of cancer cells remaining in a patient's body after treatment, even when in remission and with no symptoms. MRD testing is highl...

Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst
TipRanks 3d
Natera initiated with an Outperform at William Blair

William Blair initiated coverage of Natera (NTRA) with an Outperform rating and no price target The firm views Natera as a core, long-term holding for growth-or...

Analyst ratings

91%

of 22 ratings
Buy
90.9%
Hold
9.1%
Sell
0%

More NTRA News

TipRanks 3d
Natera: Premium-Valued Leader in MRD Positioned for Long-Term Growth and Margin Expansion

Andrew Brackmann, an analyst from William Blair, has initiated a new Buy rating on Natera (NTRA). Unlock hedge fund-level data and powerful investing tools for...

24/7 Wall St. 3d
Stanley Druckenmiller Made 1 Huge Bet That Still Looks Attractive Today and Cut 2 Top Positions

Stanley Druckenmiller Made 1 Huge Bet That Still Looks Attractive Today and Cut 2 Top Positions By Thomas Richmond Published Apr 13, 2:36PM EDT Quick Read Sta...

Stanley Druckenmiller Made 1 Huge Bet That Still Looks Attractive Today and Cut 2 Top Positions
Simply Wall St 5d
Assessing Natera Valuation After Patent Win Product Momentum And Upcoming Cancer Data

Interest in Natera (NTRA) has picked up after several company specific catalysts, including a favorable patent ruling with ongoing royalties, strong uptake of i...

Assessing Natera Valuation After Patent Win Product Momentum And Upcoming Cancer Data

People also own

Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.